159 related articles for article (PubMed ID: 8280490)
1. HLA expression in pre-invasive cervical neoplasia in relation to human papilloma virus infection.
Glew SS; Connor ME; Snijders PJ; Stanbridge CM; Buckley CH; Walboomers JM; Meijer CJ; Stern PL
Eur J Cancer; 1993; 29A(14):1963-70. PubMed ID: 8280490
[TBL] [Abstract][Full Text] [Related]
2. Dynamics of selected MHC class I and II molecule expression in the course of HPV positive CIN treatment with the use of human recombinant IFN-gamma.
Sikorski M; Bobek M; Zrubek H; Marcinkiewicz J
Acta Obstet Gynecol Scand; 2004 Mar; 83(3):299-307. PubMed ID: 14995928
[TBL] [Abstract][Full Text] [Related]
3. Analysis of MHC class I and II expression in relation to presence of HPV genotypes in premalignant and malignant cervical lesions.
Cromme FV; Meijer CJ; Snijders PJ; Uyterlinde A; Kenemans P; Helmerhorst T; Stern PL; van den Brule AJ; Walboomers JM
Br J Cancer; 1993 Jun; 67(6):1372-80. PubMed ID: 8390286
[TBL] [Abstract][Full Text] [Related]
4. Circulating human papillomavirus type 16 specific T-cells are associated with HLA Class I expression on tumor cells, but not related to the amount of viral oncogene transcripts.
de Boer MA; Jordanova ES; van Poelgeest MI; van den Akker BE; van der Burg SH; Kenter GG; Fleuren GJ
Int J Cancer; 2007 Dec; 121(12):2711-5. PubMed ID: 17724722
[TBL] [Abstract][Full Text] [Related]
5. Allelic loss of HLA class I facilitates evasion from immune surveillance in cervical intraepithelial neoplasia.
Kawase K; Taguchi A; Ishizaka A; Lin J; Ueno T; Yoshimoto D; Eguchi S; Mori S; Sone K; Mori M; Yonekura S; Hanazawa T; Maeda D; Kukimoto I; Mano H; Osuga Y; Kawana K; Kawazu M
HLA; 2024 Jun; 103(6):e15509. PubMed ID: 38837741
[TBL] [Abstract][Full Text] [Related]
6. HLA class I expression and HPV-16 sequences in premalignant and malignant lesions of the cervix.
Torres LM; Cabrera T; Concha A; Oliva MR; Ruiz-Cabello F; Garrido F
Tissue Antigens; 1993 Feb; 41(2):65-71. PubMed ID: 8386400
[TBL] [Abstract][Full Text] [Related]
7. Immune responses against human papillomavirus (HPV) type 16 virus-like particles in a cohort study of women with cervical intraepithelial neoplasia. I. Differential T-helper and IgG responses in relation to HPV infection and disease outcome.
de Gruijl TD; Bontkes HJ; Walboomers JM; Coursaget P; Stukart MJ; Dupuy C; Kueter E; Verheijen RH; Helmerhorst TJ; Duggan-Keen MF; Stern PL; Meijer CJ; Scheper RJ
J Gen Virol; 1999 Feb; 80 ( Pt 2)():399-408. PubMed ID: 10073700
[TBL] [Abstract][Full Text] [Related]
8. HLA and susceptibility to cervical neoplasia.
Krul EJ; Schipper RF; Schreuder GM; Fleuren GJ; Kenter GG; Melief CJ
Hum Immunol; 1999 Apr; 60(4):337-42. PubMed ID: 10363725
[TBL] [Abstract][Full Text] [Related]
9. Alterations in the expression of selected MHC antigens in premalignant lesions and squamous carcinomas of the uterine cervix.
Chil A; Sikorski M; Bobek M; Jakiel G; Marcinkiewicz J
Acta Obstet Gynecol Scand; 2003 Dec; 82(12):1146-52. PubMed ID: 14616262
[TBL] [Abstract][Full Text] [Related]
10. Langerhans' cell count and HLA class II profile in cervical intraepithelial neoplasia in the presence or absence of HIV infection.
Gonçalves MA; Soares EG; Fernandes AP; Fonseca BA; Bettini JS; Simões RT; Donadi EA
Eur J Obstet Gynecol Reprod Biol; 2004 Jun; 114(2):221-7. PubMed ID: 15140519
[TBL] [Abstract][Full Text] [Related]
11. Cytokine production patterns in cervical intraepithelial neoplasia: association with human papillomavirus infection.
Clerici M; Merola M; Ferrario E; Trabattoni D; Villa ML; Stefanon B; Venzon DJ; Shearer GM; De Palo G; Clerici E
J Natl Cancer Inst; 1997 Feb; 89(3):245-50. PubMed ID: 9017005
[TBL] [Abstract][Full Text] [Related]
12. HLA class II antigen expression in human papillomavirus-associated cervical cancer.
Glew SS; Duggan-Keen M; Cabrera T; Stern PL
Cancer Res; 1992 Jul; 52(14):4009-16. PubMed ID: 1377602
[TBL] [Abstract][Full Text] [Related]
13. HPV 16 infection and progression of cervical intra-epithelial neoplasia: analysis of HLA polymorphism and HPV 16 E6 sequence variants.
Bontkes HJ; van Duin M; de Gruijl TD; Duggan-Keen MF; Walboomers JM; Stukart MJ; Verheijen RH; Helmerhorst TJ; Meijer CJ; Scheper RJ; Stevens FR; Dyer PA; Sinnott P; Stern PL
Int J Cancer; 1998 Oct; 78(2):166-71. PubMed ID: 9754647
[TBL] [Abstract][Full Text] [Related]
14. Immunoglobulin G responses against human papillomavirus type 16 virus-like particles in a prospective nonintervention cohort study of women with cervical intraepithelial neoplasia.
de Gruijl TD; Bontkes HJ; Walboomers JM; Schiller JT; Stukart MJ; Groot BS; Chabaud MM; Remmink AJ; Verheijen RH; Helmerhorst TJ; Meijer CJ; Scheper RJ
J Natl Cancer Inst; 1997 May; 89(9):630-8. PubMed ID: 9150187
[TBL] [Abstract][Full Text] [Related]
15. Immunity to human papillomavirus-associated cervical neoplasia.
Stern PL
Adv Cancer Res; 1996; 69():175-211. PubMed ID: 8791682
[No Abstract] [Full Text] [Related]
16. S100, CD68, and MHC class II molecule expression in cervical high- and low-grade HPV-induced lesions.
Cassandri F; Tozetti IA; Fernandes CE; Almeida FG; Falcão GR; Scapulatempo ID; Prata TT; Padovani CT; Alves DB; Ferreira AT; Abdo MA
Rev Soc Bras Med Trop; 2012 Feb; 45(1):3-8. PubMed ID: 22370820
[TBL] [Abstract][Full Text] [Related]
17. The roles of the human major histocompatibility complex and human papillomavirus infection in cervical intraepithelial neoplasia and cervical cancer.
Odunsi KO; Ganesan TS
Clin Oncol (R Coll Radiol); 1997; 9(1):4-13. PubMed ID: 9039807
[No Abstract] [Full Text] [Related]
18. Human leukocyte antigen-G (HLA-G) expression in cervical lesions: association with cancer progression, HPV 16/18 infection, and host immune response.
Dong DD; Yang H; Li K; Xu G; Song LH; Fan XL; Jiang XL; Yie SM
Reprod Sci; 2010 Aug; 17(8):718-23. PubMed ID: 20445010
[TBL] [Abstract][Full Text] [Related]
19. Human leukocyte antigen class I/II alleles and development of human papillomavirus-related cervical neoplasia: results from a case-control study conducted in the United States.
Hildesheim A; Schiffman M; Scott DR; Marti D; Kissner T; Sherman ME; Glass AG; Manos MM; Lorincz AT; Kurman RJ; Buckland J; Rush BB; Carrington M
Cancer Epidemiol Biomarkers Prev; 1998 Nov; 7(11):1035-41. PubMed ID: 9829713
[TBL] [Abstract][Full Text] [Related]
20. The antigen-presenting environment in normal and human papillomavirus (HPV)-related premalignant cervical epithelium.
Mota F; Rayment N; Chong S; Singer A; Chain B
Clin Exp Immunol; 1999 Apr; 116(1):33-40. PubMed ID: 10209502
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
